BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 16285875)

  • 1. The management of superficial transitional cell carcinoma of the bladder: a critical assessment of contemporary concepts and future perspectives.
    Vögeli TA
    BJU Int; 2005 Dec; 96(8):1171-6. PubMed ID: 16285875
    [No Abstract]   [Full Text] [Related]  

  • 2. Interferon-gamma in the treatment of superficial and recurrent bladder carcinoma. Phase one study.
    Fontana G; Caccia P; Alladio F; Laudi M; Pigato M; Sesia G; Forni G; Giovarelli M
    Prog Clin Biol Res; 1989; 303():479-80. PubMed ID: 2506557
    [No Abstract]   [Full Text] [Related]  

  • 3. The management of superficial bladder cancer.
    Soloway MS
    Cancer; 1980 Apr; 45(7 Suppl):1856-65. PubMed ID: 6768441
    [No Abstract]   [Full Text] [Related]  

  • 4. Superficial TCC bladder cancer: the impact of tumor differentiation on recurrence, progression and survival.
    Kurth KH
    Prog Clin Biol Res; 1984; 162A():307-18. PubMed ID: 6483914
    [No Abstract]   [Full Text] [Related]  

  • 5. [Superficial bladder cancer. Open questions].
    Böhle A
    Urologe A; 1994 Nov; 33(6):536-9. PubMed ID: 7817453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bladder carcinoma treated by irradiation and surgery: interval report.
    Deweerd JH; Colby MY
    Trans Am Assoc Genitourin Surg; 1972; 64():74-8. PubMed ID: 4654525
    [No Abstract]   [Full Text] [Related]  

  • 7. Muscle-invasive bladder tumour: can the bladder be preserved?
    Sella A
    BJU Int; 2008 Nov; 102(9):1053-4. PubMed ID: 18715247
    [No Abstract]   [Full Text] [Related]  

  • 8. The optimal management of T1G3 bladder cancer.
    Emiliozzi P; Pansadoro A; Pansadoro V
    BJU Int; 2008 Nov; 102(9 Pt B):1265-73. PubMed ID: 19035891
    [No Abstract]   [Full Text] [Related]  

  • 9. The role of repeat transurethral resection in the management of high-risk superficial transitional cell bladder cancer.
    Sivalingam S; Probert JL; Schwaibold H
    BJU Int; 2005 Oct; 96(6):759-62. PubMed ID: 16153194
    [No Abstract]   [Full Text] [Related]  

  • 10. Hypericin as a potential phototherapeutic agent in superficial transitional cell carcinoma of the bladder.
    Kamuhabwa A; Agostinis P; Ahmed B; Landuyt W; van Cleynenbreugel B; van Poppel H; de Witte P
    Photochem Photobiol Sci; 2004 Aug; 3(8):772-80. PubMed ID: 15295634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [International Consensus Panel--treatment strategies for superficial bladder cancer].
    Adler S; St Niclas M
    Aktuelle Urol; 2006 Sep; 37(5):320-3; discussion 322-3. PubMed ID: 17004179
    [No Abstract]   [Full Text] [Related]  

  • 12. Evaluation criteria: a protocol to study patterns of care and their effects in patients with transitional cell carcinoma of the bladder (protocol 1).
    Prout GR; Kopp J
    Prog Clin Biol Res; 1984; 162A():285-99. PubMed ID: 6483913
    [No Abstract]   [Full Text] [Related]  

  • 13. Management of panurothelial disease in superficial bladder cancer.
    Srougi M; Antunes AA; Dall'Oglio MF; Cury J
    Nat Clin Pract Urol; 2006 May; 3(5):284-8. PubMed ID: 16691242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Re: patterns of initial transitional cell recurrence in patients after cystectomy.
    Zaghloul MS
    J Urol; 2007 Aug; 178(2):730; author reply 730. PubMed ID: 17574607
    [No Abstract]   [Full Text] [Related]  

  • 15. Editorial: Bladder cancer. How can we make a difference?
    Soloway MS
    J Urol; 2003 Nov; 170(5):1781-2. PubMed ID: 14532775
    [No Abstract]   [Full Text] [Related]  

  • 16. [Superficial bladder carcinoma -- trend of less aggressive therapies].
    Friedrich MG
    Aktuelle Urol; 2006 Jul; 37(4):254-6. PubMed ID: 16955957
    [No Abstract]   [Full Text] [Related]  

  • 17. [Value of the photodynamic method in the diagnosis of superficial bladder tumors].
    Lipiński MI; Jeromin LM
    Wiad Lek; 2004; 57 Suppl 1():192-5. PubMed ID: 15884237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contemporary management of stage T1 transitional cell carcinoma of the bladder.
    Sataa S; Yassine N; Ghassen HH; Imed BS; Mohamed C; Maher C; Ali H
    Tunis Med; 2005 Dec; 83 Suppl 12():87-9. PubMed ID: 16430077
    [No Abstract]   [Full Text] [Related]  

  • 19. [The urethra of the patient cystectomized for bladder carcinoma: role of total urethrectomy].
    Virseda JA; Bolaño N; Melchor A; Alvarez F
    Arch Esp Urol; 1987; 40(9):657-63. PubMed ID: 3326533
    [No Abstract]   [Full Text] [Related]  

  • 20. [Comparative study of treatments of bladder carcinoma: TUR, thiotepa or BCG].
    Rodrigues Netto Júnior N; Caserta Lemos G
    Arch Esp Urol; 1981; 34(5):369-74. PubMed ID: 6800309
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.